PCID2

PCI domain-containing protein 2 · Q5JVF3 · PCID2 on Sugi Atlas →

0 patent compounds predicted against PCID2, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to PCID2 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Customized Choice of Oral P2Y12 Receptor Blocker PHASE4UNKNOWN
Fixed-dose vs. Phenotype-based PrAsugrel Dose to MATCH Therapeutic Zone in Asians With Acute Coronary Syndrome PHASE4COMPLETED
Pharmacogenomic Evaluation of Antihypertensive Responses PHASE4COMPLETED
A Pharmacodynamic Study Comparing Prasugrel Versus Ticagrelor in Patients Undergoing PCI With CYP2C19 Loss-of-function: PHASE4COMPLETED
Ticagrelor in Remote Ischemic Preconditioning Study PHASE4COMPLETED
Effects of Low-dose Ticagrelor vs. Clopidogrel in Stable Patients Undergoing Elective Percutaneous Coronary Intervention PHASE4RECRUITING
Veliparib (ABT-888), an Oral PARP Inhibitor, and VX-970, an ATR Inhibitor, in Combination With Cisplatin in People With Refractory Solid Tumors PHASE1COMPLETED
A Phase I Trial of SHR3162 in Subjects With Advanced Solid Tumors PHASE1COMPLETED
Clinical and Genetic Characteristics of Coronary Artery Disease in Chinese Young Adults nanUNKNOWN
Impact of Pre-Hospital Heparin Loading in STEMI Patients for Primary PCI: The HELP-PCI-2 Trial nanRECRUITING
PCD New Gene Discovery nanCOMPLETED
Genetic Characterization of Parkinson's Disease nanCOMPLETED
Striatal and Extra-Striatal Cholinergic Terminal Density in LRRK2-PD Mutation nanRECRUITING
Genetics of Ischemic Cardiomyopathy nanCOMPLETED
Identification of Genetic Basis of Atrioventricular Conduction Defects: From Congenital Forms to Degenerative Forms nanUNKNOWN
Characterization of New Candidate Genes in Cases of Human Inherited Thrombocytopenia (CATCH) nanCOMPLETED
Family Blood Pressure Program - HyperGEN nanCOMPLETED
Multicenter Registry of Coronary Flow-Derived Indexes for Coronary Microvascular Disease (Multicenter FLOW-CMD Registry) nanACTIVE_NOT_RECRUITING
Prevalence of a Non-Expressing 11B Mutation in Aka Peoples of the Central African Republic nanCOMPLETED
Epidemiological and Genetic Studies of Body Mass Index nanCOMPLETED
Acute Coronary Syndrome Genetic Study nanUNKNOWN
Mapping Novel Disease Genes for Dilated Cardiomyopathy nanCOMPLETED
Family Blood Pressure Program - GENOA nanCOMPLETED
Family Blood Pressure Program - SAPPHIRe Network nanCOMPLETED
Study of the Pathophysiological Mechanisms Involved in Bleeding Events nanCOMPLETED
Sodium Channel Splicing in Heart Failure Trial nanCOMPLETED
Aberrant Splicings Due to Microsatellite Instability in Colorectal Cancer : Physiopathological and Clinical Impact nanUNKNOWN
Autophagy Bladder Cancer nanUNKNOWN
A Study on Risk Mutations of Vulnerability Genes of Schizophrenia nanUNKNOWN
Observational Study of Sepsis and Pneumonia to Develop Diagnostic Tests nanUNKNOWN

Related proteins — ESM-2 sequence neighbours (a PCID2 binder may also engage these)

ProteinNameSimilarity
Q8BFV2 1.000 Q8BFV2 →
Q5U3P0 1.000 Q5U3P0 →
Q2TBN6 1.000 Q2TBN6 →
Q9VTL1 1.000 Q9VTL1 →
Q95QU0 1.000 Q95QU0 →
Q5FWP8 1.000 Q5FWP8 →
A6H7B5 1.000 A6H7B5 →
Q5ZJF1 0.999 Q5ZJF1 →
O88543 0.998 O88543 →
Q60YJ7 0.998 Q60YJ7 →
Q8SYG2 0.998 Q8SYG2 →
Q5RFS2 0.998 Q5RFS2 →
Q4R898 0.998 Q4R898 →
Q28IV6 0.998 Q28IV6 →
Q7ZTN8 0.997 Q7ZTN8 →
Q8GWE6 0.995 Q8GWE6 →
Q6C1L4 0.994 Q6C1L4 →
Q6P2U9 0.994 Q6P2U9 →
Q8W575 0.994 Q8W575 →
Q9US13 0.993 Q9US13 →
O42897 0.993 O42897 →
Q9XUP3 0.992 Q9XUP3 →
Q24314 0.992 Q24314 →
P0CR48 0.992 P0CR48 →
B4I7U3 0.991 B4I7U3 →
Q3SYT7 0.991 Q3SYT7 →
P0CR49 0.991 P0CR49 →
A7SPX9 0.991 A7SPX9 →
O94308 0.991 O94308 →
Q7SD63 0.990 Q7SD63 →